Brown Ryan Edward
SEC CIK 1848718 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SRPT | Sarepta Therapeutics, Inc. | SVP, GC | 23.5K | — | $6.55M | 17 | 2022-03-01 | 2024-06-25 |
Most active insiders at SRPT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Estepan Ian Michael | COO | — | $294.2K |
| 2 | Mayo Stephen | Dir | — | $123.2K |
| 3 | Wong Ryan Ho-Yan | CFO | — | — |
| 4 | Rothfuss Cristin | EVP, GC | — | — |
| 5 | Chambers Michael Andrew | Dir | — | — |
| 6 | Rodino-Klapac Louise | Pres, R, D, Tech Ops | — | — |
| 7 | Boor Kathryn Jean | Dir | — | — |
| 8 | Nicaise Claude | Dir | — | — |
| 9 | SEVERINO MICHAEL | CEO, Dir | — | — |
| 10 | Barry Richard | Dir | — | — |
Brown Ryan Edward made no open-market trades at SRPT in the last 12 months.
Transactions 17
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2024-06-25 | 2024-06-25 | SRPT | Sarepta Therapeutics, Inc. | Brown Ryan Edward | EVP, GC | S - Sale+OE | $161.61 | -39.0K | 23.5K | -62% | -$6.30M |
| DMT | 2024-06-25 | 2024-06-21+ | SRPT | Sarepta Therapeutics, Inc. | Brown Ryan Edward | EVP, GC | M - OptEx | $62.77 | +29.8K | 34.9K | +573% | +$1.87M |
| DT | 2024-06-25 | 2024-06-24 | SRPT | Sarepta Therapeutics, Inc. | Brown Ryan Edward | EVP, GC | F - Tax | $164.64 | -2,352 | 32.6K | -7% | -$387.2K |
| M | 2024-03-11 | 2024-03-07+ | SRPT | Sarepta Therapeutics, Inc. | Brown Ryan Edward | EVP, GC | F - Tax | $122.19 | -1,405 | 28.7K | -5% | -$171.7K |
| 2024-03-06 | 2024-03-04 | SRPT | Sarepta Therapeutics, Inc. | Brown Ryan Edward | EVP, GC | F - Tax | $125.32 | -1,734 | 30.1K | -5% | -$217.3K | |
| D | 2024-03-05 | 2024-03-01 | SRPT | Sarepta Therapeutics, Inc. | Brown Ryan Edward | EVP, GC | A - Grant | $0.00 | +6,000 | 33.8K | +22% | $0 |
| D | 2024-03-05 | 2024-03-01 | SRPT | Sarepta Therapeutics, Inc. | Brown Ryan Edward | EVP, GC | F - Tax | $126.19 | -269 | 27.8K | -1.0% | -$33.9K |
| D | 2024-03-05 | 2024-03-01 | SRPT | Sarepta Therapeutics, Inc. | Brown Ryan Edward | EVP, GC | S - Sale | $125.34 | -2,000 | 31.8K | -6% | -$250.7K |
| 2023-06-05 | 2023-06-01 | SRPT | Sarepta Therapeutics, Inc. | Brown Ryan Edward | EVP, GC | F - Tax | $123.60 | -89 | 28.1K | -0.3% | -$11.0K | |
| 2023-03-10 | 2023-03-08 | SRPT | Sarepta Therapeutics, Inc. | Brown Ryan Edward | SVP, GC | F - Tax | $153.19 | -635 | 28.2K | -2% | -$97.3K | |
| D | 2023-03-08 | 2023-03-06 | SRPT | Sarepta Therapeutics, Inc. | Brown Ryan Edward | SVP, GC | A - Grant | $0.00 | +4,500 | 28.8K | +19% | $0 |
| DM | 2023-03-08 | 2023-03-06 | SRPT | Sarepta Therapeutics, Inc. | Brown Ryan Edward | SVP, GC | F - Tax | $157.21 | -1,325 | 24.3K | -5% | -$208.3K |
| 2023-03-03 | 2023-03-01 | SRPT | Sarepta Therapeutics, Inc. | Brown Ryan Edward | SVP, GC | F - Tax | $147.57 | -196 | 25.6K | -0.8% | -$28.9K | |
| 2022-06-03 | 2022-06-01 | SRPT | Sarepta Therapeutics, Inc. | Brown Ryan Edward | SVP, GC | F - Tax | $72.67 | -54 | 25.8K | -0.2% | -$3,924 | |
| D | 2022-03-08 | 2022-03-07 | SRPT | Sarepta Therapeutics, Inc. | Brown Ryan Edward | SVP, GC | A - Grant | $0.00 | +8,000 | 25.9K | +45% | $0 |
| DM | 2022-03-08 | 2022-03-04+ | SRPT | Sarepta Therapeutics, Inc. | Brown Ryan Edward | SVP, GC | F - Tax | $79.22 | -1,289 | 17.9K | -7% | -$102.1K |
| 2022-03-01 | 2022-03-01 | SRPT | Sarepta Therapeutics, Inc. | Brown Ryan Edward | SVP, GC | F - Tax | $75.05 | -184 | 19.2K | -1.0% | -$13.8K |
Purchase Sale Sale after option exercise All abbreviations